デフォルト表紙
市場調査レポート
商品コード
1402922

薬剤溶出バルーン(DEB)市場:世界の業界分析、規模、シェア、成長、動向、予測、2023年~2031年

Drug Eluting Balloon Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日: | 発行: Transparency Market Research | ページ情報: 英文 212 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
薬剤溶出バルーン(DEB)市場:世界の業界分析、規模、シェア、成長、動向、予測、2023年~2031年
出版日: 2023年11月29日
発行: Transparency Market Research
ページ情報: 英文 212 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

薬剤溶出バルーン(DEB)市場- レポートの範囲

世界の薬剤溶出バルーン(DEB)市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。レポートは、世界の薬剤溶出バルーン(DEB)の収益を提供します。 2023年を基準年、2031年を予測年とみなして、2017年から2031年の期間の市場を分析します。レポートは、2023年から2031年までの世界の薬剤溶出バルーン(DEB)市場の複合年間成長率(CAGR %)も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、薬剤溶出バルーン(DEB)市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 5億7,110万米ドル
2031年の市場価値 10億米ドル
CAGR 7.1%

このレポートは、世界の薬剤溶出バルーン(DEB)市場の競合情勢を詳しく掘り下げています。世界の薬剤溶出バルーン(DEB)市場で活動する主要企業が特定され、これらのそれぞれがさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の薬剤溶出バルーン(DEB)市場のプレーヤーの属性です。

目次

第1章 エグゼクティブサマリー

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー:世界市場

第4章 市場概要

  • 市場セグメンテーション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023~2031年

第5章 重要な洞察

  • パイプライン分析
  • COVID-19のパンデミックが業界に与える影響

第6章 市場分析と予測:製品別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:製品別、2023-2031
    • 冠状動脈
    • 末梢
    • その他
  • 市場の魅力度:製品別

第7章 市場分析と予測:技術別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:技術別、2023-2031
    • Paccocath
    • FreePac
    • TransPax
    • EnduraCoat
    • その他
  • 市場の魅力度:技術別

第8章 世界市場の分析と予測:エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測:エンドユーザー別、2023-2031
    • 病院・外来手術センター
    • カテーテルラボ
    • その他
  • 市場の魅力度:エンドユーザー別

第9章 世界市場の分析と予測:地域別

  • 主な調査結果
  • 市場金額予測:地域別、2023-2031
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度:地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場プレーヤー-競合マトリックス(企業の階層および規模別)
  • 市場シェア分析:企業別(2022年)
  • 企業プロファイル
    • Bayer AG
    • Medtronic
    • B. Braun Melsungen AG
    • Cook Medical, Inc.
    • Boston Scientific Corporation
    • Becton, Dickson and Company
    • EuroCor
    • Terumo Corporation
    • Koninklijke Philips NV
図表

List of Tables

  • Table 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 02: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 03: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 06: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 07: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 08: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 09: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 10: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 11: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 12: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
  • Table 13: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 15: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 16: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 17: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 19: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 20: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031
  • Table 21: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Product, 2023-2031
  • Table 23: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by Technology, 2023-2031
  • Table 24: Middle East & Africa Drug Eluting Balloon Market Value (US$ Mn) Forecast, by End-user 2023-2031

List of Figures

  • Figure 01: Global Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 02: Global Drug Eluting Balloon Market Value Share, by Product, 2022
  • Figure 03: Global Drug Eluting Balloon Market Value Share, by Technology, 2022
  • Figure 04: Global Drug Eluting Balloon Market Value Share, by End-user, 2022
  • Figure 05: Global Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 06: Global Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 07: Global Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 08: Global Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 09: Global Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 10: Global Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 11: Global Drug Eluting Balloon Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 12: Global Drug Eluting Balloon Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 13: North America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 14: North America Drug Eluting Balloon Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 15: North America Drug Eluting Balloon Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 16: North America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 17: North America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 18: North America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 19: North America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 20: North America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 21: North America Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 22: Europe Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
  • Figure 23: Europe Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 24: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 25: Europe Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 26: Europe America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 27: Europe Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 28: Europe Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 29: Europe Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 30: Europe Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 31: Asia Pacific Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2023-2031
  • Figure 32: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 33: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 35: Asia Pacific America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 36: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 37: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 38: Asia Pacific Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 39: Asia Pacific Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 40: Latin America Drug Eluting Balloon Market Value (US$ Mn) Forecast, 2022-2031
  • Figure 41: Latin America Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Latin America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022 and 2031
  • Figure 44: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 45: Latin America Drug Eluting Balloon Market Value Share Analysis, by Technology, 2022 and 2031
  • Figure 46: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by Technology, 2023-2031
  • Figure 47: Latin America Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 48: Latin America Drug Eluting Balloon Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 50: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 51: Middle East & Africa America Drug Eluting Balloon Market Value Share Analysis, by Product, 2022-2031
  • Figure 52: Middle East & Africa America Drug Eluting Balloon Market Attractiveness Analysis, by Product, 2023-2031
  • Figure 53: Middle East & Africa Drug Eluting Balloon Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 54: Middle East & Africa Drug Eluting Balloon Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 55: Global Drug Eluting Balloon Market Share Analysis, by Company (2022)
目次
Product Code: TMRGL2321

Drug Eluting Balloon Market - Scope of Report

TMR's report on the global drug eluting balloon market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global drug eluting balloon market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global drug eluting balloon market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the drug eluting balloon market.

Market Snapshot
Market Value in 2023US$ 571.1 Mn
Market Value in 2031US$ 1 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global drug eluting balloon market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global drug eluting balloon market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global drug eluting balloon market.

The report delves into the competitive landscape of the global drug eluting balloon market. Key players operating in the global drug eluting balloon market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global drug eluting balloon market profiled in this report.

Key Questions Answered in Global drug eluting balloon Market Report:

  • What is the sales/revenue generated by drug eluting balloon across all regions during the forecast period?
  • What are the opportunities in the global drug eluting balloon market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Drug Eluting Balloon Market - Research Objectives and Research Approach

The comprehensive report on the global drug eluting balloon market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global drug eluting balloon market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global drug eluting balloon market.

Table of Contents

1. Executive Summary

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Drug Eluting Balloon Market

4. Market Overview

  • 4.1. Market Segmentation
    • 4.1.1. Segment Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Drug Eluting Balloon Market Analysis and Forecast, 2023-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. COVID-19 Pandemic Impact on Industry

6. Drug Eluting Balloon Market Analysis and Forecast, by Product

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2023-2031
    • 6.3.1. Coronary Drug Eluting Balloon
    • 6.3.2. Peripheral Drug Eluting Balloon
    • 6.3.3. Others
  • 6.4. Market Attractiveness, by Product

7. Drug Eluting Balloon Market Analysis and Forecast, by Technology

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Technology, 2023-2031
    • 7.3.1. Paccocath
    • 7.3.2. FreePac
    • 7.3.3. TransPax
    • 7.3.4. EnduraCoat
    • 7.3.5. Others
  • 7.4. Market Attractiveness, by Technology

8. Global Drug Eluting Balloon Market Analysis and Forecast, by End-user

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals and Ambulatory Surgery Centers
    • 8.3.2. Cath Labs
    • 8.3.3. Others
  • 8.4. Market Attractiveness, by End-user

9. Global Drug Eluting Balloon Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2023-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness, by Region

10. North America Drug Eluting Balloon Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2023-2031
    • 10.2.1. Coronary Drug Eluting Balloon
    • 10.2.2. Peripheral Drug Eluting Balloon
    • 10.2.3. Others
  • 10.3. Market Attractiveness, by Product
  • 10.4. Market Value Forecast, by Technology, 2023-2031
    • 10.4.1. Paccocath
    • 10.4.2. FreePac
    • 10.4.3. TransPax
    • 10.4.4. EnduraCoat
    • 10.4.5. Others
  • 10.5. Market Attractiveness, by Technology
  • 10.6. Market Value Forecast, by End-user, 2023-2031
    • 10.6.1. Hospitals and Ambulatory Surgery Centers
    • 10.6.2. Cath Labs
    • 10.6.3. Others
  • 10.7. Market Attractiveness, by End-user
  • 10.8. Market Value Forecast, by Country, 2023-2031
    • 10.8.1. U.S.
    • 10.8.2. Canada
  • 10.9. Market Attractiveness Analysis
    • 10.9.1. By Product
    • 10.9.2. By Technology
    • 10.9.3. By End-user
    • 10.9.4. By Country

11. Europe Drug Eluting Balloon Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2023-2031
    • 11.2.1. Coronary Drug Eluting Balloon
    • 11.2.2. Peripheral Drug Eluting Balloon
    • 11.2.3. Others
  • 11.3. Market Attractiveness, by Product
  • 11.4. Market Value Forecast, by Technology, 2023-2031
    • 11.4.1. Paccocath
    • 11.4.2. FreePac
    • 11.4.3. TransPax
    • 11.4.4. EnduraCoat
    • 11.4.5. Others
  • 11.5. Market Attractiveness, by Technology
  • 11.6. Market Value Forecast, by End-user, 2023-2031
    • 11.6.1. Hospitals and Ambulatory Surgery Centers
    • 11.6.2. Cath Labs
    • 11.6.3. Others
  • 11.7. Market Attractiveness, by End-user
  • 11.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.8.1. Germany
    • 11.8.2. U.K.
    • 11.8.3. France
    • 11.8.4. Italy
    • 11.8.5. Spain
    • 11.8.6. Rest of Europe
  • 11.9. Market Attractiveness Analysis
    • 11.9.1. By Product
    • 11.9.2. By Technology
    • 11.9.3. By End-user
    • 11.9.4. By Country/Sub-region

12. Asia Pacific Drug Eluting Balloon Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2023-2031
    • 12.2.1. Coronary Drug Eluting Balloon
    • 12.2.2. Peripheral Drug Eluting Balloon
    • 12.2.3. Others
  • 12.3. Market Attractiveness, by Product
  • 12.4. Market Value Forecast, by Technology, 2023-2031
    • 12.4.1. Paccocath
    • 12.4.2. FreePac
    • 12.4.3. TransPax
    • 12.4.4. EnduraCoat
    • 12.4.5. Others
  • 12.5. Market Attractiveness, by Technology
  • 12.6. Market Value Forecast, by End-user, 2023-2031
    • 12.6.1. Hospitals and Ambulatory Surgery Centers
    • 12.6.2. Cath Labs
    • 12.6.3. Others
  • 12.7. Market Attractiveness, by End-user
  • 12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.8.1. China
    • 12.8.2. Japan
    • 12.8.3. India
    • 12.8.4. Australia & New Zealand
    • 12.8.5. Rest of Asia Pacific
  • 12.9. Market Attractiveness Analysis
    • 12.9.1. By Product
    • 12.9.2. By Technology
    • 12.9.3. By End-user
    • 12.9.4. By Country/Sub-region

13. Latin America Drug Eluting Balloon Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2023-2031
    • 13.2.1. Coronary Drug Eluting Balloon
    • 13.2.2. Peripheral Drug Eluting Balloon
    • 13.2.3. Others
  • 13.3. Market Attractiveness, by Product
  • 13.4. Market Value Forecast, by Technology, 2023-2031
    • 13.4.1. Paccocath
    • 13.4.2. FreePac
    • 13.4.3. TransPax
    • 13.4.4. EnduraCoat
    • 13.4.5. Others
  • 13.5. Market Attractiveness, by Technology
  • 13.6. Market Value Forecast, by End-user, 2023-2031
    • 13.6.1. Hospitals and Ambulatory Surgery Centers
    • 13.6.2. Cath Labs
    • 13.6.3. Others
  • 13.7. Market Attractiveness, by End-user
  • 13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.8.1. Brazil
    • 13.8.2. Mexico
    • 13.8.3. Rest of Latin America
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Product
    • 13.9.2. By Technology
    • 13.9.3. By End-user
    • 13.9.4. By Country/Sub-region

14. Middle East & Africa Drug Eluting Balloon Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2023-2031
    • 14.2.1. Coronary Drug Eluting Balloon
    • 14.2.2. Peripheral Drug Eluting Balloon
    • 14.2.3. Others
  • 14.3. Market Attractiveness, by Product
  • 14.4. Market Value Forecast, by Technology, 2023-2031
    • 14.4.1. Paccocath
    • 14.4.2. FreePac
    • 14.4.3. TransPax
    • 14.4.4. EnduraCoat
    • 14.4.5. Others
  • 14.5. Market Attractiveness, by Technology
  • 14.6. Market Value Forecast, by End-user, 2023-2031
    • 14.6.1. Hospitals and Ambulatory Surgery Centers
    • 14.6.2. Cath Labs
    • 14.6.3. Others
  • 14.7. Market Attractiveness, by End-user
  • 14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.8.1. GCC Countries
    • 14.8.2. South Africa
    • 14.8.3. Rest of Middle East & Africa
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Product
    • 14.9.2. By Technology
    • 14.9.3. By End-user
    • 14.9.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. Bayer AG
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Medtronic
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. B. Braun Melsungen AG
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Cook Medical, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Boston Scientific Corporation
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Becton, Dickson and Company
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. EuroCor
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Terumo Corporation
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Koninklijke Philips N.V.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview